Seth Klarman's position in Jazz Pharmaceuticals plc is currently worth $92.3 Million. That's 2.85% of their equity portfolio (10th largest holding). The investor owns 1.34% of the outstanding Jazz Pharmaceuticals plc stock. The investor's estimated purchase price is $117 Million, resulting in a loss of 21%.